45 selected items - PubMed - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

<< First< Prev

Page of 3

Results: 1 to 20 of 45

1.

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.

Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee.

Lancet Oncol. 2012 Apr;13(4):420-32. Epub 2012 Jan 20.

PMID:: 22265698; [PubMed - in process]

Related citations

2.

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.

Masuda N, Sagara Y, Kinoshita T, Iwata H, Nakamura S, Yanagita Y, Nishimura R, Iwase H, Kamigaki S, Takei H, Noguchi S.

Lancet Oncol. 2012 Apr;13(4):345-52. Epub 2012 Jan 20.

PMID:: 22265697; [PubMed - in process]

Related citations

3.

Aromatase inhibitors in premenopausal breast cancer.

Kelly CM, Buzdar AU.

Lancet Oncol. 2012 Apr;13(4):320-1. Epub 2012 Jan 20. No abstract available.

PMID:: 22265695; [PubMed - in process]

Related citations

4.

Breast-cancer stem cells-beyond semantics.

Badve S, Nakshatri H.

Lancet Oncol. 2012 Jan;13(1):e43-8. Review.

PMID:: 22225725; [PubMed - indexed for MEDLINE]

Related citations

5.

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.

Gianni L, Pienkowski T, Im YH, Roman L, Tseng LM, Liu MC, Lluch A, Staroslawska E, de la Haba-Rodriguez J, Im SA, Pedrini JL, Poirier B, Morandi P, Semiglazov V, Srimuninnimit V, Bianchi G, Szado T, Ratnayake J, Ross G, Valagussa P.

Lancet Oncol. 2012 Jan;13(1):25-32. Epub 2011 Dec 6.

PMID:: 22153890; [PubMed - indexed for MEDLINE]

Related citations

6.

Psychological effect of breast cancer.

Galgut C.

Lancet Oncol. 2011 Dec;12(13):1187. No abstract available.

PMID:: 22123597; [PubMed - indexed for MEDLINE]

Related citations

7.

Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.

Zahl PH, Gøtzsche PC, Mæhlen J.

Lancet Oncol. 2011 Nov;12(12):1118-24. Epub 2011 Oct 11.

PMID:: 21996169; [PubMed - indexed for MEDLINE]

Related citations

8.

Anthracyclines, HER2, and TOP2A: the verdict.

Bonnefoi HR.

Lancet Oncol. 2011 Nov;12(12):1084-5. Epub 2011 Sep 12. No abstract available.

PMID:: 21917520; [PubMed - indexed for MEDLINE]

Related citations

9.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG).

Lancet Oncol. 2011 Nov;12(12):1101-8. Epub 2011 Oct 20.

PMID:: 22018631; [PubMed - indexed for MEDLINE]

Related citations

10.

Regression of screening-detected breast cancer.

Kalager M.

Lancet Oncol. 2011 Nov;12(12):1083-4. Epub 2011 Oct 11. No abstract available.

PMID:: 21996167; [PubMed - indexed for MEDLINE]

Related citations

11.

Zoledronic acid in early-stage breast cancer.

Normanno N, De Luca A, Gallo M, Lamura L, Perrone F.

Lancet Oncol. 2011 Oct;12(11):991. No abstract available.

PMID:: 21968222; [PubMed - indexed for MEDLINE]

Related citations

12.

Adjuvant zoledronic acid for breast cancer: mechanism of action?

Kunzmann V, Wilhelm M.

Lancet Oncol. 2011 Oct;12(11):991-2. No abstract available.

PMID:: 21968221; [PubMed - indexed for MEDLINE]

Related citations

13.

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Di Leo A, Desmedt C, Bartlett JM, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H, O'Malley FP, Cardoso F, Tanner M, Munro A, Twelves CJ, Sotiriou C, Shepherd L, Cameron D, Piccart MJ, Buyse M; HER2/TOP2A Meta-analysis Study Group.

Lancet Oncol. 2011 Nov;12(12):1134-42. Epub 2011 Sep 12.

PMID:: 21917518; [PubMed - indexed for MEDLINE]

Related citations

14.

Implications of rarity of chromosome 17 polysomy in breast cancer.

Moelans CB, Reis-Filho JS, van Diest PJ.

Lancet Oncol. 2011 Nov;12(12):1087-9. Epub 2011 Sep 6. No abstract available.

PMID:: 21903472; [PubMed - indexed for MEDLINE]

Related citations

15.

US court reverses gene patent ruling for BRCA1 and BRCA2.

Brower V.

Lancet Oncol. 2011 Sep;12(9):835. No abstract available.

PMID:: 21984989; [PubMed - indexed for MEDLINE]

Related citations

16.

PARP inhibitors in cancer: moving beyond BRCA.

Telli ML.

Lancet Oncol. 2011 Sep;12(9):827-8. Epub 2011 Aug 19. No abstract available.

PMID:: 21862406; [PubMed - indexed for MEDLINE]

Related citations

17.

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, Oza A.

Lancet Oncol. 2011 Sep;12(9):852-61. Epub 2011 Aug 19.

PMID:: 21862407; [PubMed - indexed for MEDLINE]

Related citations

18.

Error occurred: cannot get document summary

PMID:: 21807337

19.

Association between KRAS rs61764370 and triple-negative breast cancer--a false positive?

Pharoah P, Antoniou A, Berchuck A, Chenevix-Trench G, Gayther S, Goode E, Milne R, Sellers T, Tyrer J.

Lancet Oncol. 2011 Aug;12(8):723-4; author reply 724. No abstract available.

PMID:: 21807336; [PubMed - indexed for MEDLINE]

Related citations

20.

Bevacizumab: public opinion might trump science.

Carlson RH.

Lancet Oncol. 2011 Aug;12(8):730. No abstract available.

PMID:: 21928489; [PubMed - indexed for MEDLINE]

Related citations

<< First< Prev

Page of 3

Supplemental Content

Filters: Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with...
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Lancet Oncol. 2012 Apr ;13(4):420-32. Epub 2012 Jan 20 .

PubMed
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitorin...
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients.
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 15 ;885-886:131-7. Epub 2012 Jan 9 .

PubMed
A subpopulation of adult skeletal muscle stem cells retains all template DNA str...
A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division.
Cell. 2012 Jan 20 ;148(1-2):112-25.

PubMed
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangem...
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.
Cell. 2012 Jan 20 ;148(1-2):59-71.

PubMed
Long-term clinical outcomes after percutaneous coronary intervention for unprote...
Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy.
Int J Cardiol. 2012 Apr 5 ;156(1):101-4. Epub 2012 Jan 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk